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Twist Regulates Cytokine Gene Expression
through a Negative Feedback Loop
that Represses NF-B Activity
(Lemaitre et al., 1996). Mutations in the genes encoding
these proteins result in susceptibility to fungal infection
and a loss in expression of the antifungal peptide droso-
mycin in response to challenge. Two other NF-B-like
proteins in Drosophila, dorsal-like immune factor (DIF)
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2 Department of Molecular Biology and in Govind, 1999; Khush et al., 2001).
Pharmacology In mammals, members of the NF-B family of tran-
Washington University Medical School scription factors, p50, p52, p65 (RelA), C-rel, and RelB,
Campus Box 8103 act as mediators of immune and inflammatory re-
660 South Euclid Avenue sponses (reviewed in Tak and Firestein, 2001; Barnes
St. Louis, Missouri 63110 and Karin, 1997). These factors bind DNA at B sites
and regulate expression of many genes with different
biological functions. Some genes regulated by NF-B
Summary lead to further NF-B activation by creating an amplifica-
tion loop. For example, the proinflammatory cytokines,
During Drosophila embryogenesis, the dorsal tran- tumor necrosis factor (TNF)-, and interleukin (IL)-1,
scription factor activates the expression of twist, a both activate and are activated by NF-B. Therefore, it
transcription factor required for mesoderm formation. is essential that not only the subcellular localization, but
We show here that the mammalian twist proteins, also the DNA binding and trans-activating potential of
twist-1 and -2, are induced by a cytokine signaling NF-B proteins be tightly regulated. Indeed, members of
pathway that requires the dorsal-related protein RelA, the NF-B family interact with numerous transcriptional
a member of the NF-B family of transcription factors. activators and repressors, adding precision and com-
Twist-1 and -2 repress cytokine gene expression plexity to their regulation
through interaction with RelA. Mice homozygous for There are two twist-like proteins in mammals, twist
a twist-2 null allele or doubly heterozygous for twist-1
and dermo-1, which share high homology with Drosoph-
and -2 alleles show elevated expression of proinflam-
ila twist (Wolf et al., 1991; Li et al., 1995). Targeted muta-
matory cytokines, resulting in perinatal death from
tion of mouse twist results in embryonic lethality at E10.5
cachexia. These findings reveal an evolutionarily con-
due to a failure in neural tube closure (Chen and Beh-served signaling circuit in which twist proteins regulate
ringer, 1995). Based on their homology and overlappingcytokine signaling by establishing a negative feedback
expression patterns (Li et al., 1995, D.S. and E.N.O.,loop that represses the NF-B-dependent cytokine
unpublished data), as well as their shared and evolution-pathway.
arily conserved interaction with the NF-B pathway,
which we demonstrate in the present study, we proposeIntroduction
renaming the mammalian twist and dermo-1 genes,
twist-1 and twist-2, respectively.The basic helix-loop-helix (bHLH) transcription factor
Here, we describe the novel function of twist in thetwist was discovered in Drosophila, based on its essen-
mouse. Our investigation into the functions of twist wastial role in mesoderm formation (Thisse et al., 1987a).
guided by the similarities that exist between the NF-B-The genetic pathway leading to the activation of twist
twist pathways in fruit flies and mice. We show that likein Drosophila includes a cascade of maternally active
Drosophila twist, mouse twist proteins function down-genes (for review, see St. Johnston and Nu¨sslein-Vol-
stream of NF-B, and that p65 (RelA) is necessary forhard, 1992). The end result of this signaling cascade is
their activation. Through the creation of twist-2 null mice,the dissociation of dorsal, an NF-B transcription factor,
we show that the lack of twist-2 results in enhancedfrom its inhibitor cactus, an IB homolog, and subse-
proinflammatory cytokine gene expression in multiplequent translocation to the nucleus where it regulates
tissues with resulting apoptosis, cachexia, and failurethe transcription of target genes, including twist (Thisse
to thrive. This phenotype is recapitulated in twist-1 andet al., 1987b). Twist and dorsal also act cooperatively
twist-2 compound heterozygotes reflecting redundancyto regulate the expression of other genes, such as snail
and dosage dependence of these genes in inhibition(Ip et al., 1992). It has been proposed that this transcrip-
of cytokine expression. The phenotype of mutant micetional synergy is mediated by direct physical interaction
appears to reflect the loss of a negative feedback loopbetween twist and dorsal (Shirokawa and Courey, 1997).
in which twist normally associates with p65 and re-Although twist has not been implicated in immune
presses the cytokine promoters. We propose a modelfunction in Drosophila, the signaling cassette leading to
its activation, which comprises spa¨tzle, toll, tube, pelle, in which twist proteins function as negative modulators
and cactus, controls the antifungal response of flies of a cytokine-NF-B-cytokine amplification loop and
discuss evolutionary and therapeutic implications of
these findings.*Correspondence: eolson@hamon.swmed.edu
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1995 and Figure 2A). To further investigate the function
of twist-2 in vivo, we generated twist-2 null mice by
replacing the first exon of the gene with a neomycin-
resistance/Cre recombinase cassette by homologous
recombination (Figure 2A). Wild-type and mutant alleles
were identified by Southern hybridization or PCR of ge-
nomic DNA (Figures 2B and 2C). Twist-2 mRNA was
undetectable in tissues from homozygous mutant mice,
but was readily detectable in wild-type and heterozy-
gous samples (Figure 2D and data not shown).
Mice heterozygous for the mutant twist-2 allele were
viable and fertile and showed no apparent phenotype.
Intercrosses of twist-2 heterozygotes in an inbred (129/
Sv) background yielded homozygous mutant offspring
at predicted Mendelian ratios. At birth, homozygous mu-
tants were indistinguishable from wild-type littermates,
but after a few days, they were recognizable by their
Figure 1. Mammalian twist Expression Is Stimulated by TNF, in an failure to thrive (Figure 2E). By three days of age, 60%
NF-B-Dependent Manner of homozygous mutants died (Figure 2F).
Immortalized mouse fibroblasts, wild-type, and p65/ were treated Prior to death, homozygous mutant mice presented
for 3.5 hr with 1 or 10 ng/ml of TNF, or left untreated, as indicated. a dramatic phenotype; they became underweight, frail,
Total RNA was isolated, and semi-quantitative RT-PCR analyses and showed signs of impaired movement and wasting
for TNF, IB, twist-1, twist-2, and ribosomal protein L7 (loading
(Figure 2E). Growth retardation was progressive, withcontrol) transcripts were performed.RT, reactions performed with-
some animals being as much as 3-fold underweight byout reverse transcriptase.
10 days of age (Figure 2G). All mutant pups showed
normal suckling behavior and we routinely found milk
in their stomachs. twist-2/ mice also showed notableResults
skin abnormalities, with dramatically thin skin and
sparse hair. Internal organs were often visible throughTNF Activates twist Expression through
the skin. There was also a complete absence of subcuta-
the NF-B Signaling Pathway
neous fat at the nape of the neck, and subsequent analy-
In Drosophila, the NF-B-like transcription factor dorsal
sis of internal organs revealed severe fat deficiency in
activates twist expression through binding to B sites the mutants (see below).
in the twist promoter (Jiang et al., 1991). To determine In light of the sequence homology and overlapping
if this aspect of twist regulation might be conserved expression patterns of twist-1 and -2, we investigated
in vertebrates, we tested whether twist-1 and -2 were whether there might be a critical dosage of the two
regulated by TNF, a well-known activator of the NF-B genes by intercrossing twist-1/ and twist-2/ mice.
pathway. Indeed, stimulation of immortalized mouse fi- Whereas mice heterozygous for either gene alone were
broblasts with TNF evoked an increase in expression normal, compound heterozygotes showed similar post-
of twist-1 and -2 transcripts (Figure 1). Twist genes were natal wasting and lethality as in twist-2/ mice (Figure
also induced by TNF in 10T1/2 and NIH3T3 cells (data 2H and data not shown). The double heterozygous mice
not shown). The IB and TNF genes, which are known were present at normal Mendelian ratios at birth.
transcriptional targets of NF-B, were also induced by
TNF stimulation. Growth Retardation, Cachexia, and Perinatal
To determine whether the induction of twist expres- Lethality in twist Mutant Mice
sion by TNF was dependent on NF-B, we measured We performed histopathologic examination of internal
twist-1 and -2 expression in immortalized fibroblasts organs of twist-2/ and twist-1//twist-2/ neonates
derived from p65/ mice. Twist-1 and -2 were not induc- to determine the cause of death. Adipose deficiency and
ible in p65/ fibroblasts (Figure 1). Expression of TNF atrophy were observed in multiple tissues from mutant
and IB was also reduced in mutant cells, consistent animals during the neonatal period (Figure 3A). In the
with their known dependence upon NF-B. These find- skin, we observed atrophy with hyperkeratosis in the
ings demonstrate that twist genes are induced by TNF epidermis. The dermis was particularly atrophic with a
in an NF-B-dependent manner, like other well-charac- prominent reduction in the amount of subcutaneous fat,
terized TNF-responsive genes. which resulted in a striking decrease in dermal thick-
ness. Hair follicles were reduced in number and often
distorted in shape (Figure 3A). Interscapular brown fat
Generation of twist-2/ and adipocytes were also atrophic and had fewer lipid cyto-
twist-1// twist-2/ Mice plasmic vacuoles than wild-type (Figure 3A). Adipose
The mouse twist-1 and –2 genes share a common intron/ deficiency was confirmed by staining liver and brown
exon organization, which likely reflects an evolutionarily fat sections with Oil Red O (Figure 3B). The spleen of the
ancient gene duplication event. Both genes consist of twist-2/ neonates showed effacement of the normal
two exons, separated by a large intron, with the entire microarchitecture due to severe lymphoid depletion in
the white pulp (Figure 3A). The thymus showed an in-coding region located in exon 1 (Chen and Behringer,
Repression of Cytokine Signaling by Twist
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Figure 2. Generation of twist-2 Null Mice and Gross Phenotype of twist-2/ and twist-1//twist-2/ Mice
(A) The wild-type twist-2 locus, the targeting vector, and the mutant locus are shown. Exons are depicted as empty (untranslated regions)
and filled (coding region) boxes. Arrowheads indicate relative position of primers used in PCR genotyping (see below).
(B) Southern blot analysis of genomic DNA. An external probe on the 3 side of the targeting site, as shown in (A) was used in Southern blot
of EcoRI-digested genomic DNA to distinguish between the wild-type (18 kb) and mutant (12 kb) alleles.
(C) Genomic DNA from mice of the indicated genotypes was analyzed by PCR using primers specific for twist-2 coding region and cre
transgene.
(D) RT-PCR was used to detect twist-2 mRNA in mouse embryo fibroblasts.
(E) Appearance of wild-type (WT) and twist-2/ mice thirteen days after birth.
(F) Survival curve of offspring derived from twist-2 heterozygote inter-crosses in 129/Sv genetic background. Wild-type (filled circles); twist-
2/ (empty circles). Percentage survival for both wild-type and mutants is defined as the number of surviving pups, at each time point, divided
by the total number pups of that genotype present at birth. Wild-type, n  31, twist-2/, n  27. Twist-1//twist-2/ compound heterozygous
mice showed similar postnatal lethality compared to twist-2/ mice (data not shown).
(G) Body weights of wild-type (filled circles) and twist-2/ (empty circles) mice during the postnatal period are shown.
(H) Gross appearance of twist-1//twist-2/ compound heterozygotes ten days after birth resembles that of twist-2/ mice.
creased number of apoptotic bodies, an abnormality 3E). On day 18 of gestation, immediately prior to birth,
the livers of twist-2/ and wild-type fetuses had compa-that progressed perinatally, resulting in effacement of
normal thymic microarchitecture, poor definition of the rable levels of glycogen (data not shown). Thus, the
absence of twist-2 interferes specifically with postnatalcortex and medulla, and thymus atrophy (Figure 3A). In
the liver, hepatocytes were also atrophic and devoid of glycogen storage and energy metabolism.
microvesicular vacuolization (data not shown), consis-
tent with the loss of hepatic glycogen stores (see below). Increased Proinflammatory Gene Expression
in twist-2 Mutant MiceSkeletal muscle also showed an increased number of
apoptotic cells and, in older pups, myofiber breakdown The cachectic phenotype of twist-2 mutant mice ap-
peared remarkably similar to the phenotype of micewas observed (data not shown and Figure 3C).
The disruption in energy homeostasis in twist-2/ overexpressing proinflammatory cytokines such as
TNF (Cheng et al., 1992). Notably, both twist-2/ andmice was also evidenced by abnormalities in glucose
metabolism and storage. Measurements of serum glu- TNF transgenic mice exhibited postnatal growth retar-
dation, adipose deficiency, skin hypoplasia with hyper-cose from one-day-old mice showed that mutants suf-
fered from hypoglycemia (Figure 3D). In addition, glyco- keratosis, abnormal hair growth, progressive wasting,
and death within 3–4 weeks after birth. We thereforegen was absent from skeletal muscle and liver (Figure
Cell
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Figure 3. Histopathology and Energy Homeostasis Defects in twist-2/ and twist-1//twist-2/ Mice
(A) Hematoxylin and eosin staining of neonatal tissue sections. Skin is from two-day-old mice and brown fat, spleen and thymus are from
five-day-old animals. e, epidermis; d, dermis; * indicates hyperkeratosis in mutant epidermis.
(B) Oil red O staining for lipid droplets in liver and interscapular brown fat of neonates.
(C) Hematoxylin and eosin staining of skeletal muscle section from hind limbs of wild-type and twist-1//twist-2/ mice at fourteen days
of age.
(D) Serum glucose measurements in wild-type (/), heterozygotes (/) and twist-2 null (/) mice.
(E) Periodic acid-Schiff (PAS) staining for glycogen (magenta) in liver and skeletal muscle.
examined whether cytokine expression might be upreg- sion was a cell-autonomous effect of twist-2 deficiency,
rather than a systemic response, we isolated dermalulated in twist-2 mutants, which could result in cachexia.
We examined the expression of transcripts for the proin- fibroblasts from wild-type and twist-2/ mice and com-
pared the levels of cytokine expression in vitro. Fibro-flammatory cytokines TNF and IL-1 in skin and skele-
tal muscle, in which twist-2 is normally expressed at blasts isolated from mutant mice and cultured in vitro
showed elevated levels of TNF and IL-1mRNA (Figurehigh levels. As shown in Figure 4A, transcripts for both
cytokines were upregulated in these perinatal tissues 4B). These findings indicated that twist-2 deficient cells
exhibited an intrinsic defect that resulted in upregulationfrom twist-2 mutants. We also observed elevation of IL-6
mRNA in mutant skin and spleen (data not shown). of proinflammatory cytokines.
Since increased expression of TNF in the skin canTo determine whether elevation of cytokine expres-
Repression of Cytokine Signaling by Twist
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Figure 4. Elevated Cytokine Expression in twist-2/ Tissues
(A) RT-PCR was performed on total RNA derived from skin and skeletal muscle of one-day-old mice. Ribosomal protein L7 was used as
loading control. Relative levels of each mRNA are shown. Values represent the mean of at least four RT-PCR experiments, each performed
on different animals.
(B) Cytokine RT-PCR was performed on total RNA from skin fibroblasts that were derived from one-day-old mice and passaged four times.
(C) Serum TNF levels were measured by examining serum-induced cytotoxicity of the TNF-sensitive cell line WEHI-13VAR, as described
in Experimental Procedures. Serial dilutions of serum from wild-type (/) and twist-2/ one-day-old mice were used in the assay. Cytotoxicity
was measured by dye uptake of degenerating cells. Serial dilutions of recombinant murine TNF (100 pg/ml) were used as standard.
lead to systemic elevation of TNF protein levels in the fect of twist-2/ cells is the upregulation of TNF, and
twist/ mice show extensive apoptosis, we testedserum (Cheng et al., 1992), with resulting cachexia and
other degenerative abnormalities resembling those in whether twist-2/ cells were hypersensitive to TNF-
induced apoptosis. To address this question, we cul-twist-2 mutant mice, we measured serum TNF protein
levels in one-day-old mice to determine whether in- tured fibroblasts from wild-type and mutant embryos in
vitro and treated them with TNF. Apoptosis was thencreased systemic TNF levels might account for the
mutant phenotype. The amount of TNF was quantified assessed using annexin V staining and annexin-positive
cells were counted by flow cytometry. Whereas bothby adding serial dilutions of serum samples to
TNF-sensitive WEHI-13VAR cells and analyzing the ef- wild-type and mutant fibroblasts showed dose-depen-
dent TNF cytotoxicity, mutant cells were sensitized tofect on viable cell numbers with a colorimetric assay.
As shown in Figure 4C, serum from twist-2 mutants the effects of TNF and showed a greater than 2-fold
increase in cell death (Figures 5C and 5D). This demon-showed significantly higher levels of TNF than from
their wild-type littermates. Collectively, these observa- strates that elevated TNF levels are indeed a contribut-
ing factor to the increased apoptosis in mutant mice.tions demonstrate that tissues that normally express
twist-2, when devoid of it, upregulate proinflammatory
cytokine mRNA levels, which can lead to a systemic Twist Binds to and Inhibits Cytokine
increase in serum cytokines. Promoter Activity
In light of the finding that mutant tissue shows elevated
cytokine expression, we tested whether twist proteinsTwist-2/ Cells Are Sensitized
to Cytokine Induced Apoptosis inhibited the activity of various cytokine promoters.
Twist-1 and -2 inhibited both basal and inducible activityTwist-2 mutant mice showed dramatic postnatal atrophy
of multiple tissues. Cellular loss was particularly appar- of the IL-1 promoter (Figure 6A). Basal activity of the
TNF promoter was also inhibited by both twists (Figureent in the dermis (Figure 5A). This prompted us to per-
form TUNEL assays for apoptosis on skin sections from 6A). The potential of twist-2 to suppress TNF expres-
sion was further tested by transiently transfecting thetwist-2/ and wild-type mice. Consistent with the lack
of apparent abnormalities in mutant embryos before TNF-luciferase reporter into primary fibroblasts de-
rived from wild-type and twist-2 mutant mice. TNF pro-birth, there was no difference in apoptosis in the skin
or other tissues analyzed at various prenatal times (data moter activity was reduced in wild-type fibroblasts,
which express twist-2, compared to twist-2/ cellsnot shown). However, the skin of one-day-old mutant
mice showed a marked increase in the number of TUNEL- (Figure 6A). Twist did not repress transcription non-spe-
cifically, since we did not observe repression of a CMV-positive nuclei in the dermis, indicative of extensive apo-
ptosis (Figure 5B). We did not observe any increase in driven promoter by twist (data not shown). These obser-
vations, together with the fact that twist-2/ cells andapoptosis in the epidermis where twist-2 is not ex-
pressed. We also observed an increase in the number tissues upregulate TNF and IL-1 mRNA, support the
conclusion that twist proteins can inhibit cytokine pro-of TUNEL-positive nuclei in some other tissues that nor-
mally express twist, such as the liver, skeletal muscle, moters.
Many cytokine promoters, including those of theand bladder from one-day-old mutant mice (data not
shown). TNF, IL-1, and IL-6 genes contain E boxes, consensus
binding sites for bHLH proteins. To determine if twistTNF is a proapoptotic factor that causes dose-
dependent cytotoxicity. Since an inherent molecular de- can bind directly to cytokine promoters, we performed
Cell
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Figure 5. Twist-2/ Cells Are Sensitized to TNF-Induced Apoptosis
(A) Skin from wild-type and twist-2/ mice was isolated at the indicated time points, sectioned, and stained with hematoxylin and eosin.
(B) TUNEL staining was performed on skin from one-day-old wild-type (/) and twist-2/ littermates. FITC-positive nuclei indicate apoptosis.
Propidium iodide (PI) was used to visualize all nuclei.
(C) Wild-type and twist-2/ fibroblasts were treated with TNF in the amounts indicated and actinomycin (100 ng/ml), as described in
Experimental Procedures. Apoptosis was assayed using annexin V labeling and flow-cytometry.
(D) The graph shows the percentage of annexin-positive cells in wild-type and mutants.
gel mobility shift assays using E box containing regions ity, using a luciferase reporter driven by four canonical
B binding sites (4xB-luc). This reporter can be inducedof the TNF or IL-1 promoters. Both twist-2 and -1
were able to bind these promoters either as homo- or by p65 or treatment with TNF. In either case, activation
of the reporter was strongly inhibited by twist-2, as wellheterodimers with the ubiquitous bHLH protein E12 (Fig-
ure 6B). To test if twist binding to cytokine promoters as twist-1 (Figure 6D). These findings suggested that
twist inhibits NF-B-dependent transcriptional activa-occurs in vivo, under physiological conditions, we per-
formed chromatin immunoprecipitation (ChIP) assays, tion. In contrast to the repressive activity of twist pro-
teins, the bHLH protein myogenin showed no repressiveusing an antibody that recognizes both twist-2 and -1.
For this assay, we used NIH3T3 cells since they show activity. These findings indicate that the cytokine inhibi-
tion by twist does not reflect a general inhibitory re-dramatic upregulation of endogenous twist-2 mRNA
after a 2 hr exposure to cytokines (data not shown). As sponse to bHLH proteins.
NF-B activity can be inhibited by several mecha-shown in Figure 6C, treatment of cells with TNF in-
duced an increase in the association of twist with the nisms, including the blockade of IB phosphorylation/
degradation and/or NF-B DNA binding. We found thatTNF and IL-1 gene promoters.
twist does not interfere with either of those processes
(data not shown). To investigate if twist and p65 proteinsTwist Represses B-Dependent Transcription
by Inhibiting p65 trans-Activation associate in vivo, we performed immunoprecipitation
experiments in COS cells transiently transfected withThe activation of NF-B is known to be pivotal for the
regulated synthesis and activity of inflammatory cyto- expression vectors encoding p65 and twist proteins. As
shown in Figure 6E, twist proteins were readily detectedkines, including TNF, IL-1, and IL-6 (for review, see
Blackwell and Christman, 1997). To further define the following immunoprecipitation with anti-p65 antibody.
Since twist physically interacts with p65, we reasonedmechanism for inhibition of the cytokine promoters by
twist, we tested whether twist could inhibit NF-B activ- that twist might directly repress p65-mediated trans-
Repression of Cytokine Signaling by Twist
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activation. To test this possibility, we fused p65 to the mammalian cytokine gene expression through its inter-
action with p65. Furthermore, we show that twist canDNA binding domain of yeast GAL4. As shown in Figure
bind to the promoters of the TNF and IL-1 genes in6F, both twist-2 and twist-1 potently suppressed activa-
vivo and in vitro. Notably, cytokines whose expressiontion of a GAL4-dependent reporter by GAL4-p65. We
is elevated in twist mutants, TNF, IL-1, and IL-6, havemapped the region of twist-2 required for inhibition of
two things in common relevant for our study: they con-p65 function by constructing a series of twist-2 deletion
tain E boxes in their promoters and their expression ismutants and testing them for their abilities to inhibit
regulated by NF-B. We propose that twist binds to Eactivity of the 4xB-luc reporter. Deletion of the con-
boxes in cytokine promoters and inhibits the activityserved C terminus of twist-2 (mutant C) abolished the
of NF-B bound to neighboring B sites. In transientability of this protein to inhibit p65-mediated trans-acti-
transfection experiments, twist inhibits p65-dependentvation. In contrast, mutants lacking the N terminus (mu-
activation of a B-dependent reporter. Thus, it appearstant N) or bHLH domain (mutant B) were as effective
that twist can also inhibit B-mediated activation inde-as the wild-type protein in suppressing NF-B activity
pendently of DNA binding, through direct contact with(Figure 6G). Thus, the C terminus is required for twist-
p65. This notion is further strengthened by twist inhibi-2-mediated inhibition of p65 activity.
tion of GAL4-p65 fusion protein activity. This mode of
regulation is also consistent with observations in Dro-Discussion
sophila in which twist can regulate its own promoter via
essential B sites, presumably through interaction withThe results of this study reveal an unanticipated function
dorsal (Jiang et al., 1991). Hence, it is possible thatfor mammalian twist proteins as NF-B-controlled anti-
twist is recruited to target promoters via protein-proteinapoptotic factors that suppress NF-B-dependent cyto-
interaction with NF-B in both flies and mammals. Bind-kine expression. The ability of twist proteins to regulate
ing of twist to an E box could provide additional specific-and be regulated by NF-B establishes this family of
ity to such an interaction. This is important since NF-transcriptional repressors as key effectors of cytokine
B participates in the control of expression of over 150signaling and energy homeostasis. A model to account
target genes in mammals, with various biological func-for the role of twist in this pathway is depicted in Figure 7.
tions (Pahl, 1999).Nuclear translocation of NF-B is sufficient to upregu-
In Drosophila, the N-terminal domain of twist has beenlate some, but not all NF-B responsive genes (Beg et
shown to mediate both binding to dorsal and synergistical., 1995). Thus, other transcription factors play essential
activation. Mammalian twist proteins are largely missingroles in modulating the NF-B response. This study
this domain, perhaps explaining why they have beenshows that twist participates in such modulation.
mostly implicated in transcriptional repression rather
than activation. However, the C-terminal regions ofPartially Redundant Functions of Mammalian
twist-1 and -2 are identical, suggesting that this domaintwist Genes
mediates their overlapping functions. We show that thisPrevious studies showed that twist-1 is required for
domain is required for inhibition of p65 activity. Theproper development of the head mesenchyme, somites,
same domain mediates interaction and repression ofand limb buds. Mice lacking twist-1 die at E10.5, show-
the MEF2 transcription factor (Spicer et al., 1996).
ing increased apoptosis in multiple tissues (Chen and
Behringer, 1995). Later potential functions of the gene
Twist, Apoptosis, and Cytokine Inhibition
have not been defined. However, mutations in human
Our results show twist expression is upregulated by
twist-1 have been shown to be responsible for Saethre- TNF in a p65-dependent manner. TNF activates two
Chotzen syndrome, which is associated with abnormali- competing pathways: a proapoptotic pathway and an
ties in fusion of the cranial bones and digit defects (How- NF-B-mediated anti-apoptotic pathway. Our data sug-
ard et al., 1997). gest that twist-2 is an NF-B-controlled anti-apoptotic
Mice heterozygous for twist-1 or twist-2 mutant alleles gene. Twist can inhibit apoptosis through downregula-
are viable, whereas double heterozygous mutants phe- tion of the ARF tumor suppressor and antagonism of
nocopy the severe cachexia and wasting seen in twist-2 the p53 pathway (Maestro et al., 1999). Although we did
null mice. These results suggest that twist-1 and -2 act not observe reduction in ARF mRNA levels in our mutant
redundantly to control an essential postnatal process mice (data not shown), we cannot exclude the possibility
and that there is a critical threshold of expression of that there is a p53-dependent mechanism leading to
these genes. apoptosis in twist-2/ mice. However, we show that
twist-2/ cells both upregulate TNF expression and
Twist-NF-B Interaction in Transcriptional are sensitized to TNF-induced apoptosis. Therefore,
Regulation in Flies and Mammals we conclude that twist can also exert its anti-apoptotic
In Drosophila, the NF-B-like protein dorsal can mediate function by specifically suppressing p65-dependent
activation or repression, depending on its interaction cytokine expression. One important class of NF-B-
with other coactivators or corepressors (Jiang et al., dependent genes is anti-apoptotic, and indiscriminant
1992; Pan and Courey, 1992; Jiang et al., 1993). Twist repression or the absence of p65 activity sensitizes cells
can also act either as an activator or a repressor of to apoptosis (Beg and Baltimore, 1996). If twist inhibited
somatic muscle development in Drosophila depending p65 indiscriminately, one would expect twist-2/ cells
on its dimer partner (Cripps et al., 1998; Castanon et to be resistant, rather than sensitized to apoptosis. Our
al., 2001). findings support the notion that twist inhibition of NF-
B is cytokine promoter-specific.We demonstrate that twist can negatively regulate
Cell
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Figure 6. Twist Inhibits the Cytokine Promoters by Directly Inhibiting p65-Mediated Transactivation
(A) Cells were transiently transfected with expression vectors for twist-1, twist-2, mouse p65, a luciferase reporter linked to the TNF promoter,
or IL-1 promoter, as indicated. Values represent the relative luciferase activity in COS cells (left image) or relative luciferase activity compared
to the basal activity in NIH3T3 cells (middle image) or wild-type fibroblasts (right image). Indicated amounts (	g) of expression vectors for
twist-1 and-2 were used.
(B) COS cells were transiently transfected with a luciferase reporter linked to four tandem copies of the NF-B binding site, an expression
vector for human p65 and the indicated amounts (ng) of expression vectors for twist-2, twist-1, and myogenin. Where indicated, samples
were treated with 10 ng/ml of TNF, for 24 hr. Values are expressed as the fold-increase in luciferase activity compared to the level of activity
with reporter plasmid alone.
(C) Gel mobility shift assay was performed using in vitro transcribed and translated E12, twist-2 and -1. Indicated regions of TNF and IL-1
gene promoters were used as a probe. Relative positions of unbound probe, twist homodimers, twist/E12 heterodimers, as well as supershifted
complexes, are indicated.
(D) Soluble chromatin was prepared from NIH3T3 cells treated with TNF and immunoprecipitated with anti-twist antibody. The final DNA
extractions were amplified using pairs of primers that cover the regions of TNF and IL-1 gene promoters as indicated.
Repression of Cytokine Signaling by Twist
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Figure 7. Twist as a Negative Modulator of
Cytokine Expression
Twist activation by NF-B is part of an evolu-
tionarily conserved pathway involved in
mesoderm formation and dorsoventral (DV)
patterning. While NF-B plays a role in the
immune response in both flies and mammals,
twist has been adopted as a repressor of cy-
tokine expression in mammals. Spz, Spa¨tzle.
Twist genes are expressed at low levels in a broad phenotypes are similar. We have attempted genetic res-
cue of twist-2 mutant mice by crossing twist-2/ andrange of post-natal tissues. Notably, the thymus, which
does not express twist, expresses TNF constitutively TNF/ mice. However, in the resulting 129/C57 mixed
genetic background, all twist-2 null mice survived to(de Kossodo et al., 1995). Low levels of twist may repress
basal levels of nuclear p65 from activating cytokine gene adulthood with only a mild phenotype, irrespective of
TNF genotype. Thus, suggesting the existence of mod-expression. Upon NF-B activation, an increase in ex-
pression of twist, and resynthesis of IB, would act co- ifier genes in the different genetic backgrounds. We
were unable to reach a conclusion regarding the specificoperatively to attenuate cytokine expression. Hence,
twist is an essential component of a negative feedback role of TNF. Nevertheless, since twist can repress mul-
tiple cytokine promoters, it seems unlikely that a singleloop that prevents the amplification and perpetuation
of NF-B-activated cytokine expression. cytokine is essential for the twist mutant phenotype.
Why are twist-2 mutant mice normal prior to birth, but
rapidly fail to thrive immediately thereafter? There is aCachexia and Twist
Cachexia is complex syndrome observed in patients physiological increase in the serum concentration of
proinflammatory cytokines during the perinatal periodwith cancer, acquired immunodeficiency syndrome
(AIDS), or chronic infections and is manifested by severe (Protonotariou et al., 1999). Furthermore, at the time
of birth, cytokines such as IL-1 are produced in highwasting of body tissue, anorexia, and anemia (Tisdale
1997). Several cytokines, including TNF, IL-1, IL-6, in- amounts by placental endothelial cells, whereas before
this their levels are low or undetectable. It has beenterferon 
, and leukemia inhibitory factor have been pro-
posed as mediators of the cachectic process. Although proposed that increased levels of TNF and IL-1 during
this period might reflect a newborn immune responsecachexia can be recapitulated in rodents by administra-
tion of sublethal doses of recombinant IL-1 (Ling et al., to the stress of delivery and to environmental changes
after birth (Protonotariou et al., 1999). Given that twist1996) or TNF (Tracey et al., 1988), it is apparent that
individual cytokines do not work alone in the in vivo functions as negative modulator of a cytokine-NF-B-
cytokine amplification loop, this physiological increasesituation, and that a complex network of multiple cyto-
kines in combination with other factors is involved in proinflammatory cytokine levels may cause demise
of twist-2/ mice after birth.(Fearon and Moses, 2002; Tisdale, 1997). Our data dem-
onstrate a novel role for twist genes in the etiology of
cachexia. The severe defects in energy homeostasis and NF-B-Twist: an Evolutionary Conserved Module
Adopted for Cytokine Repressionaccompanying wasting seen in twist-2/ and twist-1//
twist-2/ mice show striking resemblance to mouse The concept of modularity in evolutionary biology is
firmly established. Modules are shared in unrelated pro-models of TNF-induced cachexia (Cheng et al., 1992).
It is likely that the elevated cytokines in twist-2/ and cesses and are continuously moved during evolution,
leading to the co-option of genes into new regulatorytwist-1//twist-2/ mice contribute to the myriad of
metabolic changes, including depletion of lipid and gly- circuits. The NF-B-twist partnership is an example of
a module that has been conserved from insects to mam-cogen stores, which ultimately lead to death of these
animals. Interestingly, derepression of NF-B with ac- mals and is utilized during two unrelated biological pro-
cesses: dorsoventral patterning and the immune re-companying upregulation of cytokine expression lead-
ing to postnatal lethality has also been observed in IB sponse (Figure 7). In both flies and mammals, NF-B
activates twist expression during dorsoventral pat-knockout mice (Beg et al., 1995). Although the mecha-
nism of NF-B inhibition is different for IB and twist, terning (Jiang et al., 1991; Kanegae et al., 1998). During
the immune response, NF-B also induces the expres-it is not surprising that the net results of both mutant
(E) COS cells were cotransfected with vectors expressing FLAG-tagged p65, FLAG-tagged twist-2 or –1, and p50. Immunoprecipitation was
performed on cell extracts with either anti-p65 antibody or normal IgG, followed by Western blot analysis to detect FLAG-twist.
(F) COS cells were transiently transfected with expression vectors encoding twist-2, twist-1, full-length p65 fused to GAL4, and pL8G5-
luciferase reporter, which contains binding sites for the GAL4 DNA binding domain. Values are expressed as the fold-increase in luciferase
activity compared to the level of activity with reporter plasmid alone.
(G) COS cells were transiently transfected with the 4xB-luc reporter, expression vectors for p65, twist-2, and the indicated deletion mutants
of twist-2. Mutants were expressed in transfected cells at comparable levels. Values are expressed as the fold-increase in luciferase activity
compared to the level of activity with reporter plasmid alone.
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into pM1 (Sadowski et al., 1992). The TNF and IL-1 promotersion of peptides with antimicrobial properties. This study
construct contained genomic sequence from 983 to 125 andshows that in mammals twist has been adopted to nega-
from2545 to1 of the mouse TNF and IL-1 genes, respectively.tively modulate NF-B mediated cytokine activation,
Both were cloned into pGL3-Basic vector (Promega). The luciferase
thus bridging two branches of NF-B pathway and com- construct 4xB was from Clontech. Cells were transfected in 6-well
pleting a negative feedback loop (Figure 7). plates with expression constructs using FuGENE6 (Roche) following
manufacturer’s instructions.Remarkably, a similar negative feedback loop also
exists in the Drosophila NF-B pathway. Upstream of
Immunoprecipitation and Western Blottingspa¨tzle, in that pathway, is the easter protease. Muta-
Immunoprecipitation with anti-p65 rabbit polyclonal antibody (Santations in any of the downstream genes required for activ-
Cruz Biotechnology, sc7151) and Western blotting were performed
ity of the pathway lead to an increase in the amount according to manufacturer’s instructions (Santa Cruz Biotechnol-
of activated easter (Misra et al., 1998). Similarly, upon ogy). For Western blotting, we used anti-FLAG M2 monoclonal anti-
blockage of this pathway downstream of spa¨tzle, its body (Sigma, F-3165).
active form is accumulated in the embryo (Morisato and
Gel Mobility Shift AssaysAnderson, 1994). Since mutations in dorsal lead to in-
Gel mobility shift assays were performed as described (Charite´ etcreased easter activation, it has been proposed that the
al., 2001). End-labeled regions (Figure 6B) of mouse TNF and IL-initial component of the feedback loop is a transcrip-
1 gene promoters were used as a probe.
tional target of dorsal (Misra et al., 1998; see Figure 7).
Our results raise the possibility that the function of twist Blood Glucose Measurements and Serum TNF
as a key component of a negative feedback loop in this Cytotoxicity Assay
Blood/serum measurements were performed on samples derivedpathway may have been evolutionarily conserved from
from one-day-old mice. Blood glucose was measured immediatelyflies to mammals.
after sacrifice using the One Touch FastTake Blood Glucose Moni-NF-B factors are implicated in a number of pathologi-
toring System (Lifescan). For TNF measurements, serum samples
cal conditions in humans, including cancer, arthritis, were pooled according to the genotype of the animal and used in
chronic inflammation, asthma, neurodegenerative dis- a WEHI-13VAR cytotoxicity assay as described (Khabar et al., 1995).
eases, and heart disease. There are compounds already Briefly, WEHI-13VAR cells were seeded in 96-microwell plates at
2 104 per well. After overnight incubation, 2-fold dilutions of serumin widespread use that target at least in part the NF-B
or recombinant TNF (R&D Systems) were made in RPMI-1640 me-pathway. Knowledge of the molecular details of this
dium containing 25 mM HEPES, 3% FBS, and a final concentrationpathway and its negative regulation in particular should
of 0.5 mg/ml actinomycin-D, and dilutions were added in 0.1 volume
facilitate the development of more specific and potent in triplicate. After 20 hr, cytotoxicity was estimated using MTT con-
drugs for the treatment of the aforementioned condi- version and optical density (OD) measurements on a microplate
tions. reader.
Experimental Procedures RT-PCR
Total RNA was isolated using Trizol, according to the manufacturer’s
Targeting twist-2 and Generation of twist-2/ Mice recommendations (Invitrogen). The RT-PCR procedure was de-
A 7.0 kb EcoRI-NotI genomic fragment upstream of the mouse scribed previously (Sˇosˇic´ et al., 1997). All RNA samples were treated
twist-2 coding region, and a BspEI-HindIII 1.5 kb genomic fragment with DNase. PCR reactions were performed with gene-specific prim-
downstream of the twist-2 coding region, was used as long and ers that span at least one intron (primer sequences available upon
short arm, respectively, in the construction of the targeting vector. request).
A cre-FRT2-neo expression cassette was inserted between the two
regions, resulting in a vector designed to delete the entire coding TUNEL Staining
region of twist-2. RW4 ES cells were electroporated using the tar- TUNEL staining on formalin-fixed, paraffin-embedded, and sec-
geting vector. Positive clones were identified using Southern and tioned tissues was performed using the Fluorescein Apoptosis De-
PCR. Blastocyst injection was performed according to standard tection System (Promega), according to the manufacturer’s instruc-
protocols. Chimeras were bred with 129/Sv mice to establish the tions.
twist-2 deletion on the 129 inbred genetic background.
Annexin V Staining and Flow Cytometry
Histological Analysis MEFs were seeded at a density of 6  104 cells per well in 12-well
Unless otherwise indicated, animals were autopsied on the first day dishes the night before treatment. The following day, cells were
of life. Tissues were fixed in 10% buffered formalin overnight at 4C, treated with 10 or 50 ng/ml of recombinant murine TNF (R&D Sys-
paraffin-embedded according to standard protocols, and sections tems), in combination with actinomycinD (100 ng/ml), or actinomy-
(5 	m) stained with hematoxylin and eosin. Periodic acid-Schiff cinD alone. After 9 hr, medium with floating cells from each well
staining for carbohydrates and Oil red O staining for lipids was was collected and adherent cells were washed with cold PBS, fol-
performed according to standard protocols (Sheehan and Hrapchak, lowed by a 5 min treatment with 0.025% trypsin/0.01% EDTA. There-
1980). after, cells from each well were collected individually and pooled
together with fractions containing floating cells. Annexin V staining
Preparation of Mouse Embryonic and Skin Fibroblasts was performed using the Annexin V-PE Apoptosis Detection Kit (BD
Skin fibroblasts were prepared from neonatal skin explant cultures Biosciences) according to the manufacturer’s instructions. Next,
and were grown in 10% FBS. Mouse embryonic fibroblasts (MEFs) 1  104 cells were analyzed using a FACSscan Flow Cytometer
were prepared as described (Wurst and Joyner, 1993). (Becton Dickinson). All experiments were performed in triplicate and
similar results were obtained using at least three different MEF cell
lines. Cells treated with actinomycinD alone did not show a signifi-Plasmids and Transfection
cant increase in apoptosis under the experimental conditions de-Mouse twist-2 and twist-1 expression constructs were cloned into
scribed, regardless of their genotype.pcDNA3.1 (Invitrogen) as N-terminal epitope-tagged fusion proteins.
Human p65 protein (FLAG-tagged at the N terminus), mouse p65,
and human p50 were cloned into pcDNA1/Amp (Invitrogen). The ChIP Assay
ChIP assay was performed using a ChIP kit (Upstate, 17-295), ac-L8G5-luciferase construct has been described (Hollenberg et al.,
1995). GAL4-p65 was designed by cloning full-length human p65 cording to the manufacturer’s instructions. For chromatin immuno-
Repression of Cytokine Signaling by Twist
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precipitation, anti-twist rabbit polyclonal antibody was used (Santa morphogen gradient regulates the mesoderm determinant twist in
early Drosophila embryos. Genes Dev. 5, 1881–1891.Cruz Biotechnology, sc-15393).
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